Gemcitabine and vinorelbine (GV) versus cisplatin, gemcitabine and vinorelbine (CGV) as first-line treatment in advanced non small cell lung cancer: Results of a prospective randomized phase II study

1. Esteban, E.
2. Fra, J.
3. Fernández, Y.
4. Corral, N.
5. Vieitez, J.M.
6. Palacio, I.
7. De Sande, J.L.
8. Fernández, J.L.
9. Muñiz, I.
10. Villanueva, N.
11. Estrada, E.
12. Mareque, B.
13. Uña, E.
14. Buesa, J.M.
15. Lacave, A.J.